Please use this identifier to cite or link to this item: https://doi.org/10.1128/JCM.42.5.2043-2047.2004
Title: Evaluation of Advanced Reverse Transcription-PCR Assays and an Alternative PCR Target Region for Detection of Severe Acute Respiratory Syndrome-Associated Coronavirus
Authors: Drosten, C.
Chiu, L.-L.
Panning, M.
Leong, H.N.
Preiser, W.
Tam, J.S.
Günther, S.
Kramme, S.
Emmerich, P.
Ng, W.L. 
Schmitz, H.
Koay, E.S.C. 
Issue Date: May-2004
Citation: Drosten, C., Chiu, L.-L., Panning, M., Leong, H.N., Preiser, W., Tam, J.S., Günther, S., Kramme, S., Emmerich, P., Ng, W.L., Schmitz, H., Koay, E.S.C. (2004-05). Evaluation of Advanced Reverse Transcription-PCR Assays and an Alternative PCR Target Region for Detection of Severe Acute Respiratory Syndrome-Associated Coronavirus. Journal of Clinical Microbiology 42 (5) : 2043-2047. ScholarBank@NUS Repository. https://doi.org/10.1128/JCM.42.5.2043-2047.2004
Abstract: First-generation reverse transcription-PCR (RT-PCR) assays for severe acute respiratory syndrome-associated coronavirus (SARS-CoV) gave false-negative results in a considerable fraction of patients. In the present study, we evaluated two second-generation, replicase (R) gene-based, real-time RT-PCR test kits-the RealArt HPA coronavirus LC kit (Artus, Hamburg, Germany) and the LightCycler SARS-CoV quantification kit (Roche, Penzberg, Germany)-and a real-time RT-PCR assay for the nucleocapsid (N) gene. Detecting the N-gene RNA might be advantageous due to its high abundance in cells. The kits achieved sensitivities of 70.8% (Artus) and 67.1% (Roche) in 66 specimens from patients with confirmed SARS (samples primarily from the upper and lower respiratory tract and stool). The sensitivity of the N-gene assay was 74.2%. The differences in all of the sensitivities were not statistically significant (P = 0.680 [analysis of variance]). Culture cells initially contained five times more N- than R-gene RNA, but the respective levels converged during 4 days of virus replication. In clinical samples the median concentrations of R- and N-gene RNA, respectively, were 1.2 × 106 and 2.8 × 106 copies/ml (sputum and endotracheal aspirates), 43 × 10 4 and 5.5 × 104 copies/ml (stool), and 5.5 × 102 and 5.2 × 102 copies/sample (throat swabs and saliva). Differences between the samples types were significant but not between the types of target RNA. All (n = 12) samples from the lower respiratory tract tested positive in all tests. In conclusion, the novel assays are more sensitive than the first-generation tests, but they still do not allow a comprehensive ruling out of SARS. Methods for the routine sampling of sputum without infection risk are needed to improve SARS RT-PCR.
Source Title: Journal of Clinical Microbiology
URI: http://scholarbank.nus.edu.sg/handle/10635/129604
ISSN: 00951137
DOI: 10.1128/JCM.42.5.2043-2047.2004
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

43
checked on May 20, 2018

WEB OF SCIENCETM
Citations

46
checked on Apr 16, 2018

Page view(s)

25
checked on May 24, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.